[Federal Register Volume 78, Number 107 (Tuesday, June 4, 2013)]
[Notices]
[Page 33442]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-13217]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Sigma Aldrich Research Biochemicals, Inc.
Pursuant to 1301.33(a), Title 21 of the Code of Federal Regulations
(CFR), this is notice that on May 7, 2013, Sigma Aldrich Research
Biochemicals, Inc., 1-3 Strathmore Road, Natick, Massachusetts 01760-
2447, made application by letter to the Drug Enforcement Administration
(DEA) to be registered as a bulk manufacturer of the following basic
classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Mephedrone (4-Methyl-N-methylcathinone) I
(1248).
MDPV (3,4-Methylenedioxypyrovalerone) I
(7535).
Methylone (3,4-Methylenedioxy-N- I
methylcathinone) (7540).
Sufentanil (9740).......................... II
------------------------------------------------------------------------
The company plans to manufacture reference standards.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than August 5, 2013.
Dated: May 24, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-13217 Filed 6-3-13; 8:45 am]
BILLING CODE 4410-09-P